Cancer
Collection and use of family history in oncology clinics
Hemminki K, et al. J Clin Oncol 2014 Sep
Hemminki K, et al. J Clin Oncol 2014 Sep
Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma
Curl P, et al. PLoS One 2014;9(9):e107255
Curl P, et al. PLoS One 2014;9(9):e107255
Gene panel testing for inherited cancer risk
Hall MJ, et al. J Natl Compr Canc Netw 2014 Sep;12(9):1339-46
Hall MJ, et al. J Natl Compr Canc Netw 2014 Sep;12(9):1339-46
Genetic counseling for hereditary breast and gynecologic cancer syndromes at a community hospital
Haber KM, et al. Conn Med 2014 Aug;78(7):417-20
Haber KM, et al. Conn Med 2014 Aug;78(7):417-20
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014
Daly MB, et al. J Natl Compr Canc Netw 2014 Sep;12(9):1326-38
Daly MB, et al. J Natl Compr Canc Netw 2014 Sep;12(9):1326-38
Easy-to-use decision aids for improved cancer family history collection and use among oncology practices
Sie AS, et al. J Clin Oncol 2014 Sep
Sie AS, et al. J Clin Oncol 2014 Sep
Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery.
Badani KK, et al. BJU Int. 2014 Apr 30. doi: 10.1111/bju.12789.
Badani KK, et al. BJU Int. 2014 Apr 30. doi: 10.1111/bju.12789.
Improving cancer treatment decisions with genomic data, Forbes, Sep 4
Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor-positive, lymph-node-negative early-stage breast cancer in Japan
Yamauchi H, et al. BMC Health Serv Res 2014 Sep;14(1):372
Yamauchi H, et al. BMC Health Serv Res 2014 Sep;14(1):372
To reflex or not: Additional BRCA1/2 testing in Ashkenazi Jewish individuals without founder mutations
Petrucelli N, et al. J Genet Couns 2014 Sep
Petrucelli N, et al. J Genet Couns 2014 Sep
No hay comentarios:
Publicar un comentario